SoftBank Corp.
SoftBank Corp. (SFBQF) Financial Performance & Income Statement Overview
Analyze SoftBank Corp. (SFBQF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
SoftBank Corp. (SFBQF) Income Statement & Financial Overview
Review SoftBank Corp. SFBQF income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1732.89B | $1659.38B | $1616.36B | $1535.72B |
| Cost of Revenue | $943.91B | $865.78B | $812.09B | $762.33B |
| Gross Profit | $788.97B | $793.60B | $804.27B | $773.39B |
| Gross Profit Ratio | $0.46 | $0.48 | $0.50 | $0.50 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $615.15B | $553.35B | $521.89B | $510.20B |
| Operating Expenses | $615.15B | $553.35B | $521.89B | $510.20B |
| Total Costs & Expenses | $1559.06B | $1419.13B | $1333.98B | $1272.53B |
| Interest Income | $1.75B | $3.27B | $2.15B | $4.51B |
| Interest Expense | $27.81B | $19.36B | $32.48B | $37.70B |
| Depreciation & Amortization | $194.50B | $186.25B | $180.32B | $186.95B |
| EBITDA | $360.89B | $422.22B | $462.28B | $501.39B |
| EBITDA Ratio | $0.21 | $0.25 | $0.29 | $0.33 |
| Operating Income | $173.82B | $240.25B | $282.38B | $263.19B |
| Operating Income Ratio | $0.10 | $0.14 | $0.17 | $0.17 |
| Other Income/Expenses (Net) | -$38.51B | -$22.14B | -$30.65B | $13.55B |
| Income Before Tax | $135.31B | $218.11B | $251.73B | $276.74B |
| Income Before Tax Ratio | $0.08 | $0.13 | $0.16 | $0.18 |
| Income Tax Expense | $25.70B | $67.22B | $58.51B | $73.34B |
| Net Income | $87.19B | $112.75B | $161.35B | $162.51B |
| Net Income Ratio | $0.05 | $0.07 | $0.10 | $0.11 |
| EPS | $1.83 | $2.36 | $3.31 | $3.45 |
| Diluted EPS | $1.82 | $2.29 | $3.35 | $3.38 |
| Weighted Avg Shares Outstanding | $47.31B | $47.42B | $48.24B | $47.14B |
| Weighted Avg Shares Outstanding (Diluted) | $47.65B | $49.97B | $47.67B | $48.08B |
The company's financials show resilient growth, with revenue advancing from $1535.72B in Q1 2024 to $1732.89B in Q4 2024. Gross profit remained healthy with margins at 46% in Q4 2024 compared to 50% in Q1 2024. Operating income hit $173.82B last quarter, sustaining a consistent 10% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $360.89B. Net income dropped to $87.19B, while earnings per share reached $1.83. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan